Jyothy Labs has made a significant business move by selling its entire 75% stake in Jyothy Kallol Bangladesh Limited (JKBL) to Kallol Enterprise Limited. This deal, valued at BDT 3,01,92,134, means JKBL is no longer a subsidiary of Jyothy Labs.
Board Approval & Transaction Details
On March 25, 2025, Jyothy Labs’ Board of Directors approved the transaction. The company confirmed that the deal was executed at arm’s length, following SEBI’s LODR Regulations, 2015.
With this sale, Kallol Enterprise Limited—which previously held a 25% stake—now owns JKBL completely. The two companies signed a Share Purchase Agreement (SPA) to finalize the deal.
Impact on Jyothy Labs’ Financials
As of March 31, 2024, JKBL contributed BDT 520 lakh to Jyothy Labs’ revenue, making up only 0.14% of the company’s total earnings. Its net worth stood at BDT 1,023 lakh, representing 0.42% of Jyothy Labs’ consolidated net worth.
With such a small contribution, this sale is unlikely to have a major financial impact on Jyothy Labs. Instead, it appears to be a strategic move to streamline operations and focus on core markets.
About the Buyer – Kallol Enterprise Limited
The acquiring company, Kallol Enterprise Limited, is based in the Tejgaon Industrial Area, Dhaka, Bangladesh. It has been a long-term partner of Jyothy Labs, making this a logical transition.
While this deal is considered a related-party transaction, Jyothy Labs clarified that it was carried out at market value and does not fall under any Scheme of Arrangement under SEBI’s LODR Regulations.
Regulatory Compliance
As per SEBI’s LODR Regulations, 2015, Jyothy Labs has submitted all required disclosures, ensuring full transparency in the transaction.
What’s Next for Jyothy Labs?
With this sale, Jyothy Labs seems to be restructuring its international presence and possibly shifting focus towards stronger growth areas. The company’s next moves will be crucial in shaping its future strategy.
For more insights on corporate actions and stock market updates, check out Moneyphobia.
